Adult type vs. childhood hepatocellular carcinoma - Are they the same or different lesions? Biology, natural history, prognosis, and treatment

Medical and Pediatric Oncology

Volumn 39, Issue 5, 2002, Pages 519-523

  Czauderna, P ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adult oncology; Cancer biology; Cancer treatment; Childhood cancer; Hepatocellular carcinoma; Prognostic factors

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADOLESCENT; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER SURGERY; CANCER THERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHILD; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; POLAND; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036836485     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10178     Document Type: Conference Paper

References (39)

1. Moore SW, Hesseling PB, Wessels G, et al. Hepatocellular carcinoma in children. Pediatr Surg Int 1997;12:266-270.
2. Bellani FF, Massimino M. Liver tumors in childhood: Epidemiology and clinics. J Surg Oncol Suppl 1993;3:119-121.
3. Parkin DM, Stiller CA, Draper GJ, et al. The international incidence of childhood cancer. Int J Cancer 1988;42:511-520.
4. Chen JC, Chen CC, Chen WJ, et al. Hepatocellular carcinoma in children: Clinical review and comparison with adult cases. J Pediatr Surg 1998;33:1350-1354.
5. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, et al. NIH conference. Hepatocellular carcinoma. Ann Intern Med 1988;108:390-401.
6. LaBrecque D. Neoplasia of the liver. In: Kaplowitz N, editor. Liver and biliary diseases. Baltimore: Williams & Wilkins; 1996. p 391-438.
7. Von Schweinitz D, Burger D, Weinel P, et al. Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH. Klin Padiatr 1992;204:214-220.
8. Giacomantonio M, Ein SH, Mancer K, et al. Thirty years of experience with pediatric primary malignant liver tumors. J Pediatr Surg 1984;19:523-526.
9. Moller TR, Garwicz S, Corraziari I, et al. Survival of children with liver tumours in Europe 1978-1989. Eur J Cancer 2001;37:744-749.
10. Von Schweinitz D, Fuchs J, Mildenberger H. Surgical strategy in pediatric liver malignancies. Langenbecks Arch Chir Suppl Kongressbd 1996;113:1091-1094.
11. King DR, Ortega J, Campbell J, et al. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg 1991;26:1074-1080.
12. Gauthier F, Valayer J, Thai BL, et al. Hepatoblastoma and hepatocarcinoma in children: Analysis of series of 29 cases. J Pediatr Surg 1986;21:424-429.
13. Schmidt A, Schmidt P, Haas RJ, et al. Primary liver tumors in childhood: An analysis of 19 cases. Langenbecks Arch Chir 1988;373:159-165.
14. Gururangan S, O'Meara A, MacMahon C, et al. Primary hepatic tumours in children: A 26-year review. J Surg Oncol 1992;50:30-36.
15. Tagge EP, Tagge DU, Reyes J, et al. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: Impact on survival. J Pediatr Surg 1992;27:292-297.
16. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin and delayed surgery for childhood hepatoblastoma: A successful approach. Results of the first prospective study of the international society of pediatric oncology (SIOP) - SIOPEL 1. J Clin Oncol 2000;18:3819-3828.
17. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000;36:1418.
18. Weinberg AG, Finegold MJ. Primary hepatic tumours of childhood. Hum Pathol 1983;14:512-537.
19. Kew MC. Hepatocellular carcinoma with and without cirrhosis. Gastroenterology 1989;97:136-139.
20. Ducreux M, Elias D, Rougier P, et al. Treatment of hepatocellular carcinoma in the presence of liver cirrhosis. J Chir (Paris) 1995;132:279-286.
21. Chang MH. Hepatocellular carcinoma in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998;39:366-370.
22. Kim H, Lee MJ, Kim MR, et al. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: Comparison study of childhood and adult hepatocellular carcinoma. Liver 2000;20:173-178.
23. Kluge P, Zimmerman A, Prokurat A. Hepatocellular tumors of older children - the distinct pathology provoking the plea of a new classification (abstract). Med Ped Oncol 2000;35:192(O-90).
24. Saab S, Yao F. Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature. Dig Dis Sci 1996;41:1981-1985.
25. Farhi DC, Shikes RH, Murari PJ, et al. Hepatocellular carcinoma in young people. Cancer 1983;52:1516-1525.
26. Haas JE, Muczynski KA, Krailo M. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989;64:1082-1095.
27. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Cancer 1996;77:2217-2222.
28. Colombo M. The natural history of hepatocellular carcinoma in western countries. Hepatogastroenterol 1998;45:1221-1226.
29. Superina R, Bilik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996;31:835-839.
30. Mathurin P, Rixe O, Carbonell N, et al. Review article: Overview of medical treatments in unresectable hepatocellular carcinoma - an impossible meta-analysis? Aliment Pharmacol Ther 1998;12:111-126.
31. Whang-Peng J, Chao Y. Clinical trials of HCC in Taiwan. Hepatogastroenterol 1998;45:1937-1943.
32. Shen DW, Lu YG, Chin KV, et al. Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression. J Cell Sci 1991;98:317-322.
33. Chao Y, Chan WK, Birkhofer MJ, et al. Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer 1998;78:34-39.
34. Hata Y. Takada N, Sasaki F, et al. Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents. J Pediatr Surg 1992;27:724-727.
35. Trinchet JC, Beaugrand M. Hepatocellular carcinoma: Treatment with arterial chemo-embolization. Pressr Med 1994;14:831-833.
36. Adam R, Akpinar E, Johann M, et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997;225:39-38.
37. Ravikumar TS, Pizzorno G, Bodden W, et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol 1994;12:2723-2736.
38. Venook AP. Treatment of hepatocellular carcinoma: Too many options? J Clin Oncol 1994;12:1323-1334.
39. Simonetti RG, Liberati A, Angiolini C, et al. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Ann Oncol 1997;8:117-136.